We are live on ! Find out more
ACS

Archford Capital Strategies Portfolio holdings

AUM $987M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$664M
AUM Growth
+$47M
Cap. Flow
+$39.3M
Cap. Flow %
5.91%
Top 10 Hldgs %
29.81%
Holding
266
New
8
Increased
100
Reduced
120
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Healthcare 4.52%
3 Financials 4.24%
4 Industrials 3.47%
5 Consumer Discretionary 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
176
McKesson
MCK
$102B
$483K 0.07%
948
FN icon
177
Fabrinet
FN
$20.5B
$477K 0.07%
1,802
-52
-3% -$12K
FINX icon
178
Global X FinTech ETF
FINX
$166M
$470K 0.07%
16,080
-1,049
-6% -$27.7K
DIS icon
179
Walt Disney
DIS
$178B
$469K 0.07%
4,935
-31
-0.6% -$2.85K
XLI icon
180
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
$459K 0.07%
3,297
CAT icon
181
Caterpillar
CAT
$393B
$457K 0.07%
1,161
-2
-0.2% -$691
VOT icon
182
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20B
$454K 0.07%
1,804
DHR icon
183
Danaher
DHR
$145B
$451K 0.07%
1,661
+6
+0.4% +$1.59K
IBMN
184
DELISTED
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
$432K 0.07%
16,234
-4,793
-23% -$128K
PWR icon
185
Quanta Services
PWR
$102B
$424K 0.06%
1,364
-38
-3% -$10K
FTNT icon
186
Fortinet
FTNT
$118B
$423K 0.06%
5,106
-118
-2% -$8.06K
AZN icon
187
AstraZeneca
AZN
$246B
$422K 0.06%
2,704
-626
-19% -$101K
EMR icon
188
Emerson Electric
EMR
$91.4B
$420K 0.06%
3,730
KEYS icon
189
Keysight
KEYS
$60.6B
$420K 0.06%
2,641
-44
-2% -$6.26K
MILN
190
Global X Millennial Consumer ETF
MILN
$102M
$409K 0.06%
9,587
-352
-4% -$13.8K
ABT icon
191
Abbott
ABT
$192B
$406K 0.06%
3,464
-163
-4% -$17.9K
IBMO icon
192
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$569M
$404K 0.06%
15,815
-5,040
-24% -$129K
IBMM
193
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
$399K 0.06%
15,308
-4,882
-24% -$127K
GNOM icon
194
Global X Genomics & Biotechnology ETF
GNOM
$87.2M
$395K 0.06%
8,883
-335
-4% -$15K
JMST icon
195
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
$392K 0.06%
7,724
-338
-4% -$17.2K
TSLA icon
196
Tesla
TSLA
$1.29T
$388K 0.06%
1,769
+358
+25% +$81.6K
DDOG icon
197
Datadog
DDOG
$86.5B
$385K 0.06%
2,980
+131
+5% +$15.3K
AOM icon
198
iShares Core Moderate Allocation ETF
AOM
$1.77B
$374K 0.06%
8,386
-340
-4% -$14.9K
PBE icon
199
Invesco Biotechnology & Genome ETF
PBE
$358M
$372K 0.06%
5,314
-194
-4% -$13.4K
URA icon
200
Global X Uranium ETF
URA
$6.31B
$369K 0.06%
12,244
-324
-3% -$8.7K

Similar funds

Archford Capital Strategies's Q3 2024 Portfolio in Review

As of Q3 2024, Archford Capital Strategies held 266 positions worth $664M, up 7.6% from $617M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Archford Capital Strategies deployed $39.3M of net new capital in Q3 2024, opening 8 new positions and adding to 100 existing holdings. Its largest new stake was ProShares UltraPro Short QQQ: 1,800 shares worth $315K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $391K trimmed.

  • Archford Capital Strategies's largest Q3 2024 buy was ProShares UltraPro Short QQQ: 1,800 shares worth $315K.
  • Archford Capital Strategies added most to Schwab US Large-Cap Growth ETF in Q3 2024, an estimated $18M increase.
  • Archford Capital Strategies's biggest Q3 2024 reduction was Apple, cutting an estimated $391K.
  • Archford Capital Strategies fully exited Berkshire Hathaway Class A in Q3 2024, selling an estimated $612K.
  • Archford Capital Strategies's ten largest holdings make up 30% of its $664M portfolio in Q3 2024.
  • Archford Capital Strategies opened 8 new positions and closed 12 in Q3 2024.
  • Archford Capital Strategies's portfolio value rose 7.6% quarter-over-quarter to $664M.

Based on Archford Capital Strategies's 13F filing for Q3 2024, filed 15 Oct 2024.